Conter V - Search Results

1

Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease.

Zuna J, Hovorkova L, Krotka J, Koehrmann A, Bardini M, Winkowska L, Fronkova E, Alten J, Koehler R, Eckert C, Brizzolara L, Trkova M, Stuchly J, Zimmermann M, De Lorenzo P, Valsecchi MG, Conter V, Stary J, Schrappe M, Biondi A, Trka J, Zaliova M, Cazzaniga G, Cario G. Zuna J, et al. Among authors: conter v. Leukemia. 2022 Dec;36(12):2793-2801. doi: 10.1038/s41375-022-01668-0. Epub 2022 Aug 6. Leukemia. 2022. PMID: 35933523

2

Prognostic value of nephromegaly at diagnosis of childhood acute lymphoblastic leukemia.

D'Angelo P, Mura R, Rizzari C, Conter V, Bellini F, Valsecchi MG, Manganini C, Silvestri D, Masera G. D'Angelo P, et al. Among authors: conter v. Acta Haematol. 1995;94(2):84-9. doi: 10.1159/000203979. Acta Haematol. 1995. PMID: 7484018

3

Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.

Conter V, Aricò M, Valsecchi MG, Rizzari C, Testi AM, Messina C, Mori PG, Miniero R, Colella R, Basso G, et al. Conter V, et al. J Clin Oncol. 1995 Oct;13(10):2497-502. doi: 10.1200/JCO.1995.13.10.2497. J Clin Oncol. 1995. PMID: 7595699 Clinical Trial.

4

Human monocytic leukemia expresses low levels of asparagine synthase and is potentially sensitive to L-asparaginase.

Codegoni AM, Biondi A, Conter V, Masera G, Rambaldi A, D'Incalci M. Codegoni AM, et al. Among authors: conter v. Leukemia. 1995 Feb;9(2):360-1. Leukemia. 1995. PMID: 7869776 No abstract available.

5

Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster groups.

Conter V, Schrappe M, Aricó M, Reiter A, Rizzari C, Dördelmann M, Valsecchi MG, Zimmermann M, Ludwig WD, Basso G, Masera G, Riehm H. Conter V, et al. J Clin Oncol. 1997 Aug;15(8):2786-91. doi: 10.1200/JCO.1997.15.8.2786. J Clin Oncol. 1997. PMID: 9256120

6

Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome.

Schrappe M, Aricò M, Harbott J, Biondi A, Zimmermann M, Conter V, Reiter A, Valsecchi MG, Gadner H, Basso G, Bartram CR, Lampert F, Riehm H, Masera G. Schrappe M, et al. Among authors: conter v. Blood. 1998 Oct 15;92(8):2730-41. Blood. 1998. PMID: 9763557 Free article.

7

Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) acute lymphoblastic leukemia studies, 1982-1995.

Conter V, Aricò M, Valsecchi MG, Basso G, Biondi A, Madon E, Mandelli F, Paolucci G, Pession A, Rizzari C, Rondelli R, Zanesco L, Masera G. Conter V, et al. Leukemia. 2000 Dec;14(12):2196-204. doi: 10.1038/sj.leu.2401963. Leukemia. 2000. PMID: 11187911

8

Molecular remission induced by gemtuzumab ozogamicin associated with donor lymphocyte infusions in t(4;11) acute lymphoblastic leukemia relapsed after transplantation.

Balduzzi A, Rossi V, Corral L, Bonanomi S, Longoni D, Rovelli A, Conter V, Biondi A, Uderzo C. Balduzzi A, et al. Among authors: conter v. Leukemia. 2003 Nov;17(11):2247-8. doi: 10.1038/sj.leu.2403134. Leukemia. 2003. PMID: 12960967 No abstract available.

9

Importance of minimal residual disease testing during the second year of disease: still no answer?

Aricò M, Conter V, Valsecchi MG, Masera G. Aricò M, et al. Among authors: conter v. J Clin Oncol. 2003 Dec 1;21(23):4463-4; author reply 4464-5. doi: 10.1200/JCO.2003.99.093. J Clin Oncol. 2003. PMID: 14645441 No abstract available.

10

Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome.

Heerema NA, Harbott J, Galimberti S, Camitta BM, Gaynon PS, Janka-Schaub G, Kamps W, Basso G, Pui CH, Schrappe M, Auclerc MF, Carroll AJ, Conter V, Harrison CJ, Pullen J, Raimondi SC, Richards S, Riehm H, Sather HN, Shuster JJ, Silverman LB, Valsecchi MG, Aricò M; Acute Lymphoblastic Leukemia Study Groups; ALL-BFM; CoALL; AIEOP; DCLSG; FRALLE; CCG; DFCI; POG; St Jude; UKALL. Heerema NA, et al. Among authors: conter v. Leukemia. 2004 Apr;18(4):693-702. doi: 10.1038/sj.leu.2403324. Leukemia. 2004. PMID: 15044926

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

216 results

Search Page